Viewing Study NCT00318578



Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00318578
Status: COMPLETED
Last Update Posted: 2007-08-15
First Post: 2006-04-25

Brief Title: Prognosis Factors Associated With Convulsive Status Epilepticus in Adults
Sponsor: Versailles Hospital
Organization: Versailles Hospital

Study Overview

Official Title: Prognosis Factors Associated With Convulsive Status Epilepticus in Adults A Multicenter Cohort Study
Status: COMPLETED
Status Verified Date: 2007-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the study is to evaluate prospectively prognosis factors associated with convulsive status epilepticus CSE in adults hospitalized in intensive care units
Detailed Description: Status epilepticus is a neurologic and medical emergency associated with high mortality and morbidity rates According to the operational definition Convulsive Status Epilepticus CSE is defined as a single clinical seizure lasting more than 10 min or two or more repeated seizures over a period of more than 10 minutes without intervening recovery of consciousness

There are a few to date in literature reporting prognosis factors associated with this condition and at this time there are no published data considering an operational definition of CSE

In a retrospective study considering an operational definition we identified a seizure duration of 15 min associated with poor outcome not yet published

The principal goal of this study is to evaluate factors associated with outcome in CSE in particular seizure duration of more than 15 minutes

The secondary goals are to evaluate the epidemiology and management at every stage of CSE thus redefined

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None